ALSCG Blog Navigating HTA: AstraZeneca's Fasenra and NICE

A Pricentric Brief by Sean Skulski According to the World Health Organization (WHO), Health Technology Assessment (HTA) is a multidisciplinary, systematic evaluation of the properties, effects, and/or impacts of health technology to inform a policy decision making. During HTA, authorities evaluate the social, economic, organization, and ethical issues of a health intervention or health technology. When [...]The post Navigating HTA: AstraZeneca's Fasenra and NICE appeared first on Alliance Life Sciences.